Pharmacology

Action Mechanism of Action Reference
AGONIST Tumor necrosis factor receptor superfamily member 18 agonist

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Glioblastoma 2 D005909 ClinicalTrials
Carcinoma, Squamous Cell 2 D002294 ClinicalTrials
Head and Neck Neoplasms 1 D006258 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4594558
FDA SRS O440IW9NHN